BALA CYNWYD, Pa., July 27, 2016 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Sequenom, Inc.
("Sequenom" or "the Company") (Nasdaq- SQNM-News) for possible
breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Laboratory Corporation
of America Holdings ("Lab Corp.").
Click here to learn more about the investigation
http://brodsky-smith.com/1107-sqnm-sequenom-inc.html, or call:
877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Sequenom shareholders will
receive only $2.40 in cash for each
share of Sequenom stock they own. The investigation concerns
whether the Board of Sequenom breached their fiduciary duties
to shareholders and whether Lab Corp. is underpaying for the
Company. The transaction may undervalue the Company and would
result in a loss for many long-term Sequenom shareholders. For
example, Sequenom stock traded at $4.65 per share on May 4,
2015 and traded at $3.20 per
share as recently as July 17, 2015.
In addition, the transaction may undervalue the molecular
diagnostic testing services that Sequenom develops and
commercializes for the oncology market.
If you own shares of Sequenom stock and wish to discuss the
legal ramifications of the investigation, or have any
questions, you may e-mail or call the law office of Brodsky &
Smith, LLC who will, without obligation or cost to you, attempt to
answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith,
LLC, Two Bala Plaza, Suite 510, Bala
Cynwyd, PA 19004, by visiting
http://brodsky-smith.com/1107-sqnm-sequenom-inc.html, or
calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and have
successfully recovered millions of dollars for our clients and
shareholders. Attorney advertising. Prior results do not guarantee
a similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert--brodsky--smith-llc-announces-an-investigation-of-the-board-of-directors-of-sequenom-inc--sqnm-300304916.html
SOURCE Brodsky & Smith, LLC